A Phase II Dose-Ranging Study Evaluating the Efficacy and...

  • Main
  • 2016 / 03
  • A Phase II Dose-Ranging Study Evaluating the Efficacy and...

A Phase II Dose-Ranging Study Evaluating the Efficacy and Safety of the Orexin Receptor Antagonist Filorexant (MK-6096) in Patients with Primary Insomnia

Connor, KM, Mahoney, E, Jackson, S, Hutzelmann, J, Zhao, X, Jia, N, Snyder, E, Snavely, D, Michelson, D, Roth, T, Herring, WJ
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
International Journal of Neuropsychopharmacology
DOI:
10.1093/ijnp/pyw022
Date:
March, 2016
File:
PDF, 707 KB
english, 2016
Conversion to is in progress
Conversion to is failed